mRNA-based COVID-19 booster vaccination is highly effective and cost-effective in Australia

BACKGROUND: Australia implemented an mRNA-based booster vaccination strategy against the COVID-19 Omicron variant in November 2021. We aimed to evaluate the effectiveness and cost-effectiveness of the booster strategy over 180 days. METHODS: We developed a decision-analytic Markov model of COVID-19...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Rui, Liu, Hanting, Fairley, Christopher K, Ong, Jason J, Guo, Yuming, Lu, Pengyi, Zou, Zhuoru, Xie, Li, Zhuang, Guihua, Li, Yan, Shen, Mingwang, Zhang, Lei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Science 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9894775/
https://www.ncbi.nlm.nih.gov/pubmed/36781332
http://dx.doi.org/10.1016/j.vaccine.2023.01.075

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9894775/
https://www.ncbi.nlm.nih.gov/pubmed/36781332
http://dx.doi.org/10.1016/j.vaccine.2023.01.075

Ejemplares similares